Type III hereditary angio-oedema: Clinical and biological features in a French cohort

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 65, Issue 10, 2010, Pages 1331-1336

  Vitrat Hincky, V ^a   Gompel, A ^b,c   Dumestre Perard, C ^a,d   Boccon Gibod, I ^a,c   Drouet, C ^c,d,e   Cesbron, J Y ^a,d   Lunardi, J ^a,d,e   Massot, C ^a,c,d   Bouillet, L ^a,c,d  

^a GRENOBLE UNIVERSITY HOSPITAL   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c National Angiodema Reference Centre   (France)

^d UNIV GRENOBLE ALPES   (France)

^e Angio Oedema Exploration Laboratory   (France)

Author keywords

angioedema; C1inhibitor; oestrogen; pregnancy

Indexed keywords

ANTIHISTAMINIC AGENT; COMPLEMENT COMPONENT C1S INHIBITOR; ESTROGEN; METHYLPREDNISOLONE; ORAL CONTRACEPTIVE AGENT; PREDNISONE; TRANEXAMIC ACID;

ADULT; ANGIONEUROTIC EDEMA; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; DISEASE EXACERBATION; DISEASE SEVERITY; FEMALE; FRANCE; GENETIC ANALYSIS; GENETIC MARKER; HETEROZYGOSITY; HUMAN; MALE; PREGNANCY; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD;

ANGIOEDEMAS, HEREDITARY; COHORT STUDIES; COMPLEMENT C1 INACTIVATOR PROTEINS; ESTROGENS; FACTOR XII; FAMILY; FEMALE; FRANCE; GENETIC VARIATION; HUMANS; MALE; PREGNANCY; RETROSPECTIVE STUDIES; TRANEXAMIC ACID;

EID: 77956438524     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/j.1398-9995.2010.02368.x     Document Type: Article

References (31)

1. Cicardi M, Agostoni A. Hereditary angioedema. N Engl J Med 1996 334 : 1666 1667.
2. Agostoni A, Aygoren-Pursun E, Binkley KE, Blanch A, Bork K, Bouillet L et al. Hereditary and acquired angioedema: problems and progress: proceedings of the third C1 esterase inhibitor deficiency workshop and beyond. J Allergy Clin Immunol 2004 3 (Suppl. S51 S131.
3. Zuraw BL. Clinical practice. Hereditary angioedema. N Engl J Med 2008 359 : 1027 1036.
4. Bas M, Adams V, Suvorava T, Niehues T, Hoffmann TK, Kojda G et al. Nonallergic angioedema: role of bradykinin. Allergy 2007 62 : 842 856.
5. Nussberger J, Cugno M, Amstutz C, Cicardi M, Pellacani A, Agostoni A et al. Plasma bradykinin in angio-oedema. Lancet 1998 351 : 1693 1697.
6. Bork K, Barnstedt SE, Koch P, Traupe H. Hereditary angioedema with normal C1-inhibitor activity in women. Lancet 2000 356 : 213 217.
7. Binkley KE, Davis A III. Clinical, biochemical, and genetic characterization of a novel estrogen-dependent inherited form of angioedema. J Allergy Clin Immunol 2000 106 : 546 550.
8. Martin L, Degenne D, Toutain A, Ponard D, Watier H. Hereditary angioedema type III: an additional French pedigree with autosomal dominant transmission. J Allergy Clin Immunol 2001 107 : 747 748.
9. Dewald G, Bork K. Missense mutations in the coagulation factor XII (Hageman factor) gene in hereditary angioedema with normal C1 inhibitor. Biochem Biophys Res Commun 2006 343 : 1286 1289.
10. Cichon S, Martin L, Hennies HC, Müller F, Van Driessche K, Karpushova A et al. Increased activity of coagulation factor XII (Hageman factor) causes hereditary angioedema type III. Am J Hum Genet 2006 79 : 1098 1104.
11. Drouet C, Alibeu C, Ponard D, Arlaud GJ, Colomb MG. A sensitive method to assay blood complement C1-inhibitor activity. Clin Chim Acta 1988 174 : 121 130.
12. Bouillet L, Ponard D, Drouet C, Jullien D, Massot C. Angioedema and oral contraception. Dermatology 2003 206 : 106 109.
13. Dumestre-Pérard C, Osmundson J, Lemaire-Vieille C, Thielens N, Grives A, Favier B et al. Activation of classical pathway of complement cascade by soluble oligomers of prion. Cell Microbiol 2007 9 : 2870 2879.
14. Drouet C, Blanch A, Roche O, Monnier N, Duponchel C, Kalmar L et al. Mutation analysis of the C1INH gene. J Allergy Clin Immunol 2004 114 : S66 S74.
15. Bork K, Gul D, Dewald G. Hereditary angio-oedema with normal C1 inhibitor in a family with affected women and men. Br J Dermatol 2006 154 : 542 545.
16. Serrano C, Guilarte M, Tella R, Dalmau G, Bartra J, Gaig P et al. Estrogen-dependent hereditary angio-oedema with normal C1 inhibitor: description of six new cases and review of pathogenic mechanisms and treatment. Allergy 2008 63 : 735 741.
17. Prieto A, Tornero P, Rubio M, Fernández-Cruz E, Rodriguez-Sainz C. Missense mutation Thr309Lys in the coagulation factor XII gene in a Spanish family with hereditary angioedema type III. Allergy 2009 64 : 284 286.
18. Bork K, Wulff K, Hardt J, Witzke G, Staubach P. Hereditary angioedema caused by missense mutations in the factor XII gene: clinical features, trigger factors, and therapy. J Allergy Clin Immunol 2009 124 : 129 134.
19. Bork K, Gul D, Hardt J, Dewald G. Hereditary angioedema with normal C1 inhibitor: clinical symptoms and course. Am J Med 2007 120 : 987 992.
20. Bork K. Hereditary angioedema with normal c1 inhibition. Curr Allergy Asthma Rep 2009 9 : 280 285.
21. Bouillet L, Ponard D, Rousset H, Cichon S, Drouet C. A case of hereditary angio-oedema type III presenting with C1-inhibitor cleavage and a missense mutation in the F12 gene. Br J Dermatol 2007 156 : 1063 1065.
22. Farsetti A, Misiti S, Citarella F, Felici A, Andreoli M, Fantoni A et al. Molecular basis of estrogen regulation of Hageman factor XII gene expression. Endocrinology 1995 136 : 5076 5083.
23. Martin L, Raison-Peyron N, Nothen MM, Cichon S, Drouet C. Hereditary angioedema with normal C1 inhibitor gene in a family with affected women and men is associated with the p.Thr328Lys mutation in the F12 gene. J Allergy Clin Immunol 2007 120 : 975 977.
24. Bork K, Fischer B, Dewald G. Recurrent episodes of skin angioedema and severe attacks of abdominal pain induced by oral contraceptives or hormone replacement therapy. Am J Med 2003 114 : 294 298.
25. Drouet C, Désormeaux A, Robillard J, Ponard D, Bouillet L, Martin L et al. Metallopeptidase activities in hereditary angioedema: effect of androgen prophylaxis on plasma aminopeptidase P. J Allergy Clin Immunol 2008 121 : 429 433.
26. Bork K, Kleist R, Hardt J, Witzke G. Kallikrein-kinin system and fibrinolysis in hereditary angioedema due to factor XII gene mutation Thr309Lys. Blood Coagul Fibrinolysis 2009 20 : 325 332.
27. Cicardi M, Bergamaschini L, Zingale LC, Gioffré D, Agostoni A. Idiopathic nonhistaminergic angioedema. Am J Med 1999 106 : 650 654.
28. Bouillet L, Ponard D, Drouet C, Massot C. Non-histaminic angioedema management: diagnostic and therapeutic interest of tranexamic acid. Rev Med Interne 2004 25 : 924 926.
29. Deeks ED. Icatibant. Drugs 2010 70 : 73 81.
30. Bouillet L, Boccon-Gibod I, Ponard D, Drouet C, Cesbron JY, Dumestre-Perard C et al. Bradykinin receptor 2 antagonist (Icatibant) for hereditary angioedema type III attacks. Ann Allergy Asthma Immunol 2009 103 : 448.
31. Duan QL, Binkley K, Rouleau GA. Genetic analysis of Factor XII and bradykinin catabolic enzymes in a family with estrogen-dependent inherited angioedema. J Allergy Clin Immunol 2009 123 : 906 910.